Bio:cap 2026 brings together the global Life-Science and AI ecosystem at the City Cube on the Berlin exhibition grounds. The event blends the focus of an investor conference with the energy of a festival: curated matchmaking, inspiring keynotes, deep-dive sessions, and interactive panels highlight innovations in biotech, diagnostics, and AI-driven health solutions. Networking is at the heart of bio:cap, with dedicated zones for founder-investor 1:1s, a Capital Zone for VCs and family offices, and informal lounge areas for spontaneous conversations. Attendees also experience Berlin’s unique vibe: move between idea-sparking installations, discover partner innovations at their booths, or grab snacks and drinks at a Berlin-style Späti.
Berlin’s dense network of leading universities, research institutions, and biotech startups provides the perfect environment for innovation and collaboration, making it an ideal host city for bio:cap. The event is shaped in close partnership with the Charité, BIH and HPI, supported by leading figures such as Prof. Heyo Kroemer (CEO, Charité), Prof. Eicke Latz (immunologist and life-science investor), and Prof. Ariel Stern (HPI), a leading voice at the intersection of digital health, economics, and policy.
On the second evening, the official bio:cap Investival Party turns a hand-picked Berlin venue into a hub for vibrant discussions and new collaborations.
By combining strategic networking, cutting-edge science, and Berlin’s dynamic lifestyle, bio:cap showcases the future of Life Sciences and AI, making it a must-attend event for startups, investors, researchers, and policymakers worldwide.